Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

Holly Hagan, Mary H. Latka, Jennifer V. Campbell, Elizabeth T. Golub, Richard S. Garfein, David A. Thomas, Farzana Kapadia, Steffanie A. Strathdee

Research output: Contribution to journalArticle


Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

Original languageEnglish (US)
Pages (from-to)669-672
Number of pages4
JournalClinical Infectious Diseases
Issue number5
StatePublished - Mar 1 2006


ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this